Balkrishan Simba Gill
2020
In 2020, Balkrishan Simba Gill earned a total compensation of $2.2M as Chief Executive Officer at Evelo Biosciences, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $400,400 |
|---|---|
| Option Awards | $1,208,125 |
| Salary | $560,000 |
| Total | $2,168,525 |
Gill received $1.2M in option awards, accounting for 56% of the total pay in 2020.
Gill also received $400.4K in non-equity incentive plan and $560K in salary.
Rankings
In 2020, Balkrishan Simba Gill's compensation ranked 5,163rd out of 13,090 executives tracked by ExecPay. In other words, Gill earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,163 out of 13,090 | 61st |
Division Manufacturing | 2,117 out of 5,621 | 62nd |
Major group Chemicals And Allied Products | 846 out of 2,254 | 63rd |
Industry group Drugs | 730 out of 1,954 | 63rd |
Industry Pharmaceutical Preparations | 547 out of 1,459 | 63rd |
Source: SEC filing on April 26, 2021.
Gill's colleagues
We found two more compensation records of executives who worked with Balkrishan Simba Gill at Evelo Biosciences in 2020.
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019